Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Hut 8 Mining Q3 2025 Earnings Preview (SeekingAlpha) +++ HUT 8 Aktie -5,58%

ATYR Aktie

 >ATYR Aktienkurs 
0.73 EUR    -4.6%    (Tradegate)
Ask: 0.735 EUR / 4100 Stück
Bid: 0.73 EUR / 4200 Stück
Tagesumsatz: 8035 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
ATYR Aktie über LYNX handeln
>ATYR Performance
1 Woche: -7,2%
1 Monat: +27,0%
3 Monate: -81,5%
6 Monate: -74,7%
1 Jahr: -72,7%
laufendes Jahr: -79,1%
>ATYR Aktie
Name:  ATYR PHARMA INC. DL -,001
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US0021202025 / A2PM86
Symbol/ Ticker:  471A (Frankfurt) / ATYR (NASDAQ)
Kürzel:  FRA:471A, ETR:471A, 471A:GR, NASDAQ:ATYR
Index:  -
Webseite:  https://www.atyrpharma.co..
Profil:  Atyr Pharma Inc. is a biotechnology company dedica..
>Volltext..
Marktkapitalisierung:  73.55 Mio. EUR
Unternehmenswert:  15.8 Mio. EUR
Umsatz:  -
EBITDA:  -59.56 Mio. EUR
Nettogewinn:  -57.76 Mio. EUR
Gewinn je Aktie:  -0.69 EUR
Schulden:  10.99 Mio. EUR
Liquide Mittel:  14.92 Mio. EUR
Operativer Cashflow:  -48.19 Mio. EUR
Bargeldquote:  5.17
Umsatzwachstum:  -100%
Gewinnwachstum:  -4.65%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  1 Insider kaufte innerhalb der letzten 30 Tage Aktien im Wert von 911.801 USD.
Suchwörter:  ATYR
Letzte Datenerhebung:  03.11.25
>ATYR Kennzahlen
Aktien/ Unternehmen:
Aktien: 97.99 Mio. St.
Frei handelbar: 96.76%
Rückkaufquote: -65.73%
Mitarbeiter: 59
Umsatz/Mitarb.: -
Analysten:
Analystenrating: Buy
Kursziel: 880.75%
Bewertung:
KGV: -
KGV lG: -
KUV: -
KBV: 1.13
PEG-Ratio: -
EV/EBITDA: -
Rentabilität:
Bruttomarge: -
Gewinnmarge: -
Operative Marge: -
Managementeffizenz:
Gesamtkaprendite: -64.24%
Eigenkaprendite: -85.18%
>ATYR Peer Group

Es sind 597 Aktien bekannt.
 
03.11.25 - 15:33
 ATYR INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In ATYR To Contact Him Directly To Discuss Their Options (PR Newswire)
 
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In ATyr To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in ATyr between January 16, 2025 and September 12, 2025 and......
03.11.25 - 14:48
 The Gross Law Firm Notifies aTyr Pharma, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ATYR (PR Newswire)
 
NEW YORK, Nov. 3, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of aTyr Pharma, Inc. (NASDAQ: ATYR). Shareholders who purchased shares of ATYR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff......
03.11.25 - 09:12
 aTyr Pharma, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - ATYR (PR Newswire)
 
LOS ANGELES, Nov. 3, 2025 /PRNewswire/ -- The DJS Law Group announces that it is investigating claims on behalf of investors of aTyr Pharma, Inc. ("aTyr" or "the Company") (NASDAQ: ATYR) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the......
03.11.25 - 08:24
 ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm (PR Newswire)
 
LOS ANGELES, Nov. 3, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against aTyr Pharma, Inc. ("aTyr" or "the Company") (NASDAQ: ATYR) for violations of §§10(b) and 20(a) of the Securities Exchange Act......
31.10.25 - 13:48
 Shareholders that lost money on aTyr Pharma, Inc.(ATYR) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More (PR Newswire)
 
NEW YORK, Oct. 31, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in aTyr Pharma, Inc. ("aTyr" or the "Company") (NASDAQ: ATYR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of aTyr investors who were adversely......
30.10.25 - 23:51
 ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit (PR Newswire)
 
NEW YORK, Oct. 30, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of aTyr Pharma, Inc. (NASDAQ: ATYR) between January 16, 2025 and September 12, 2025, both dates inclusive (the "Class Period"), of the important December 8,......
30.10.25 - 13:48
 The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 8, 2025 in aTyr Lawsuit - ATYR (PR Newswire)
 
NEW YORK, Oct. 30, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of aTyr Pharma, Inc. (NASDAQ: ATYR). Shareholders who purchased shares of ATYR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff......
30.10.25 - 13:45
 ATYR Shareholder Alert: New aTyr Pharma, Inc. (ATYR) Securities Class Filed; Class Period Significantly Enlarged -- Hagens Berman (PR Newswire)
 
ATYR Investors with Losses Encouraged to Contact the Firm SAN FRANCISCO, Oct. 30, 2025 /PRNewswire/ -- A new class action complaint has been filed against aTyr Pharma, Inc. (NASDAQ: ATYR) and certain of its top executives, significantly enlarging the alleged class period covered by the......
29.10.25 - 21:45
 aTyr Pharma Inc. (ATYR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit (PR Newswire)
 
LOS ANGELES, Oct. 29, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against aTyr Pharma Inc. ("aTyr" or the "Company") (NASDAQ: ATYR). IF YOU SUFFERED A LOSS ON YOUR ATYR......
28.10.25 - 21:57
 aTyr Pharma Inc. (ATYR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit (PR Newswire)
 
LOS ANGELES, Oct. 28, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to aTyr Pharma Inc. ("aTyr" or the "Company") (NASDAQ: ATYR) have opportunity to lead the securities fraud class action lawsuit. IF YOU ARE AN INVESTOR WHO SUFFERED A......
28.10.25 - 14:36
 SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma (PR Newswire)
 
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In aTyr To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in aTyr between January 16, 2025 and September 12, 2025 and would like to......
28.10.25 - 13:48
 Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 8, 2025 in aTyr Pharma, Inc. Lawsuit - ATYR (PR Newswire)
 
NEW YORK, Oct. 28, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in aTyr Pharma, Inc. ("aTyr" or the "Company") (NASDAQ: ATYR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of aTyr investors who were adversely......
28.10.25 - 00:39
 Class Action Reminder: ATYR Investors Should Contact Robbins LLP for Information About Leading the aTyr Pharma, Inc. Class Action Lawsuit (PR Newswire)
 
SAN DIEGO, Oct. 27, 2025 /PRNewswire/ -- Company: aTyr Pharma, Inc. (NASDAQ: ATYR) is a clinical stage biotechnology company leveraging evolutionary intelligence to translate tRNA synthetase biology into new therapies for fibrosis and inflammation. Class Period: January 16, 2025 -......
27.10.25 - 23:30
 ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit (PR Newswire)
 
NEW YORK, Oct. 27, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of aTyr Pharma, Inc. (NASDAQ: ATYR) between January 16, 2025 and September 12, 2025, both dates inclusive (the "Class Period"), of the important December 8,......
27.10.25 - 13:48
 Shareholders that lost money on aTyr Pharma, Inc.(ATYR) should contact The Gross Law Firm about pending Class Action - ATYR (PR Newswire)
 
NEW YORK, Oct. 27, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of aTyr Pharma, Inc. (NASDAQ: ATYR). Shareholders who purchased shares of ATYR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff......
27.10.25 - 08:57
 aTyr Pharma, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - ATYR (PR Newswire)
 
LOS ANGELES, Oct. 27, 2025 /PRNewswire/ -- The DJS Law Group announces that it is investigating claims on behalf of investors of aTyr Pharma, Inc. ("aTyr" or "the Company") (NASDAQ: ATYR) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether......
27.10.25 - 08:54
 ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm (PR Newswire)
 
LOS ANGELES, Oct. 27, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against aTyr Pharma, Inc. ("aTyr" or "the Company") (NASDAQ: ATYR) for violations of §§10(b) and 20(a) of the Securities Exchange Act......
24.10.25 - 19:39
 ATYR Investor Alert: New aTyr Pharma, Inc. (ATYR) Securities Class Filed; Class Period Significantly Enlarged -- Hagens Berman (PR Newswire)
 
SAN FRANCISCO, Oct. 24, 2025 /PRNewswire/ -- A new class action complaint has been filed against aTyr Pharma, Inc. (NASDAQ: ATYR) and certain of its top executives, significantly enlarging the alleged class period covered by the ongoing securities litigation. The new class action, Kingv.......
24.10.25 - 18:03
 aTyr Pharma Inc. (ATYR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit (PR Newswire)
 
BENSALEM, Pa., Oct. 24, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against aTyr Pharma Inc. ("aTyr" or the "Company") (NASDAQ: ATYR). IF YOU ARE AN INVESTOR WHO......
24.10.25 - 15:03
 Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 8, 2025 in aTyr Pharma, Inc. Lawsuit - ATYR (PR Newswire)
 
NEW YORK, Oct. 24, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in aTyr Pharma, Inc. ("aTyr" or the "Company") (NASDAQ: ATYR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of aTyr investors who were adversely......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Wer heilt, hat recht. - Hippokrates
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!